The efficacy of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a pilot study.
- Conditions
- lung fibrosisscarring of the long100084011002496710024450
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 11
-IPF patients
-Diagnosis of IPF, including probable and possible diagnosis according to ATS/ERS criteria
-Written informed consent
-TLCOc >= 25% (pred) and FVC >= 50% (pred)
-6MWD >= 150 m
-Being clinically stable
-Absolute decline in TLCOc and FVC should be less than 10% in the past 6 months.
-Participation in a formal rehabilitation program within 4 months of start of study
-Musculoskeletal disorders
-Severe cardiac diseases (ejection fraction < 30%, daily angina, or otherwise specified by treating cardiologist)
-Unable to understand informed consent
-Other conditions that hamper the use of a walk-bike
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Change in total score in health-related quality of life questionnaire SGRQ ,<br /><br>measured at week 9 and week 18 compared to baseline.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Change in exercise capacity measures at week 9 and week 18 compared to baseline<br /><br>(distance (m) during 6-minute-walk-test and average steps per day)<br /><br><br /><br>Change in score in health related quality of life questionnaires K-BILD abd<br /><br>GAD-7 , measured at 9 and 18 weeks compared with baseline.<br /><br>This questionnaire is self-administered.<br /><br><br /><br>Change in component scores (symptoms, activity and impact) in health-related<br /><br>quality of life measured with SGRQ at week 9 and 18 compared to baseline.</p><br>